{"id":604622,"date":"2022-06-20T18:18:01","date_gmt":"2022-06-20T18:18:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=604622"},"modified":"2022-06-20T18:18:01","modified_gmt":"2022-06-20T18:18:01","slug":"chronic-venous-ulceration-market-to-observe-stupendous-growth-during-the-forecast-period-201932-key-players-merakris-rheacell-serenagroup-mediwound-prp-concepts-amnio-technology-and-others","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/chronic-venous-ulceration-market-to-observe-stupendous-growth-during-the-forecast-period-201932-key-players-merakris-rheacell-serenagroup-mediwound-prp-concepts-amnio-technology-and-others_604622.html","title":{"rendered":"Chronic Venous Ulceration Market to Observe Stupendous Growth During the Forecast Period (2019-32) | Key Players – Merakris, Rheacell, SerenaGroup, MediWound, PRP Concepts, Amnio Technology, and Others"},"content":{"rendered":"
\n
\"Chronic<\/a><\/div>\n
\n
Delveinsight Business Research LLP<\/div>\n<\/div>\n<\/div>\n
DelveInsight’s “Chronic Venous Ulceration Market Insights, Epidemiology, and Market Forecast 2032” report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Chronic Venous Ulceration Market size, share, and trends in the seven major market (7MM) (i.e., the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).<\/div>\n

The Chronic Venous Ulceration market<\/strong> report covers emerging drugs, current treatment practices, market share of the individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice\/algorithm, market drivers & barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market. <\/p>\n

Chronic Venous Ulceration (CVU) market <\/strong><\/p>\n

The Chronic Venous Ulceration (CVU) market size in the seven major markets was estimated to be USD 1,626.4 Million in 2020. The Chronic Venous Ulceration (CVU) Market size is expected to increase during the forecast period owing to the rise in the number of prevalent cases in the 7MM.<\/strong><\/em><\/p>\n

 <\/em><\/p>\n

\"Chronic<\/p>\n

Chronic Venous Ulceration: An Overview<\/strong><\/p>\n

Venous ulcer is defined as a full-thickness defect of the skin, most frequently in the ankle region, that fails to heal spontaneously and is sustained by chronic venous disease. Chronic vein ulcer (CVU) is a defect in the skin below the level of the knee that occurs due to improper functioning of venous valves, persisting for more than six weeks with no tendency to heal after three or more months. Hence, also known as leg ulcers or lower limb ulcers or venous ulcers or venous insufficiency, or stasis ulcer. <\/p>\n

Treatment options for venous ulcers include leg elevation, compression therapy, dressings, and medications. Compression therapy is the standard of care for CVU. Medications for CVU include pentoxifylline, aspirin, simvastatin along with other antibiotics, antiseptics, and anti-inflammatory drugs. Surgical management may be considered for ulcers that are large in size, of prolonged duration, or refractory to conservative measures.<\/em><\/p>\n

Chronic Venous Ulceration Market Key Facts<\/strong><\/p>\n